Flaza 30mg Tablet DEFLAZACORT

Introduction to Flaza 30mg Tablet

Flaza 30mg Tablet is a medication primarily used to treat a condition known as Duchenne muscular dystrophy (DMD) in children aged 5 and older. This condition leads to muscle weakening, and Flaza 30mg Tablet helps manage its symptoms.

Composition of Flaza 30mg Tablet

The active ingredient in Flaza 30mg Tablet is Deflazacort. This component is crucial for its therapeutic effects, helping to reduce inflammation and suppress the immune system.

Uses of Flaza 30mg Tablet

• Management of Duchenne muscular dystrophy (DMD) in children.
• Reduction of inflammation in various conditions.
• Suppression of the immune system to prevent overactivity.

Side effects of Flaza 30mg Tablet

Common side effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious side effects:

• Allergic reactions such as rash, itching, or swelling
• Severe dizziness
• Trouble breathing

Precautions of Flaza 30mg Tablet

Flaza 30mg Tablet should not be taken by individuals who are allergic to Deflazacort or any of its ingredients. Caution is advised during pregnancy and breastfeeding. It is important not to stop taking this medication suddenly, as it can lead to steroid withdrawal syndrome, causing symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.

How to Take Flaza 30mg Tablet

• Take the tablet once daily by mouth.
• The recommended dose is about 0.9 mg for each kilogram of body weight.
• It can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Flaza 30mg Tablet

Flaza 30mg Tablet is an effective medication for managing Duchenne muscular dystrophy in children. It is important to follow the prescribed dosage and take necessary precautions to avoid potential side effects. Always consult with a healthcare professional before starting or stopping the medication.